451 related articles for article (PubMed ID: 1280084)
1. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
Nabe T; Yamamura H; Kohno S; Ohata K
Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
[TBL] [Abstract][Full Text] [Related]
2. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
3. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
Shin HY; Kim JS; An NH; Park RK; Kim HM
Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
[TBL] [Abstract][Full Text] [Related]
4. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
[TBL] [Abstract][Full Text] [Related]
6. Anti-allergic effects of ketanserin on animal models of allergic reactions.
Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
[TBL] [Abstract][Full Text] [Related]
7. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
[TBL] [Abstract][Full Text] [Related]
8. A tiaramide derivative, 5-chloro-3-(4-hydroxypiperadinocarbonylmethyl)benzothiazoline-2-one (HPR-611), a potent inhibitor of anaphylactic chemical mediator release--a distinctive feature from disodium cromoglycate.
Nabe T; Hashii H; Matsubara S; Yasui K; Yamamura H; Horiba M; Watanabe-Kohno S; Ohata K
J Pharmacobiodyn; 1992 Dec; 15(12):673-9. PubMed ID: 1284281
[TBL] [Abstract][Full Text] [Related]
9. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
10. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
[TBL] [Abstract][Full Text] [Related]
11. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
Terasawa M; Goto K; Maruyama Y
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
[TBL] [Abstract][Full Text] [Related]
12. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
13. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
[TBL] [Abstract][Full Text] [Related]
14. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
Gonzalez Alvarez R; Kazimierczak W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
[TBL] [Abstract][Full Text] [Related]
15. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
Tasaka K; Akagi M; Izushi K; Mio M
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices].
Ohmori K; Ishii H; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):441-9. PubMed ID: 6186585
[TBL] [Abstract][Full Text] [Related]
17. [Anti-allergic effects of tazanolast [butyl 3'-(1H-tetrazol-5-yl) oxanilate, WP-833] metabolites].
Hashimoto T; Edanami K; Naito A; Sano K; Fushimi H; Goto M
Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):159-66. PubMed ID: 1695192
[TBL] [Abstract][Full Text] [Related]
18. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
[TBL] [Abstract][Full Text] [Related]
20. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
